Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Adenocarcinoma × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 21 Carcinoma, Basal Cell 10 Uterine Cervical Dysplasia 7 Melanoma 6 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Precancerous Conditions 3 Glioblastoma 3 Condylomata Acuminata 3 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Papillomavirus Infections 2 Non-Muscle Invasive Bladder Neoplasms 2 Keratosis 2 Hutchinson's Melanotic Freckle 2 HIV Infections 2 Glioma 2 Astrocytoma 2 Warts 1 Vulvar Neoplasms 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sialorrhea 1 Sexually Transmitted Diseases 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Satisfaction 1

Interventions

Gemcitabine 26 Fluorouracil 23 Oxaliplatin 19 Cisplatin 18 Leucovorin 15 Bevacizumab 14 Paclitaxel 12 130-nm albumin-bound paclitaxel 12 Capecitabine 11 Docetaxel 10 Albumin-Bound Paclitaxel 10 Irinotecan 9 Carboplatin 9 pembrolizumab 6 Radiotherapy 6 Pemetrexed 6 Nivolumab 6 Cyclophosphamide 6 Ramucirumab 5 Erlotinib Hydrochloride 5 Trastuzumab 4 Everolimus 4 Cetuximab 4 vandetanib 3 trastuzumab deruxtecan 3 sargramostim 3 folfirinox 3 Sorafenib 3 Ipilimumab 3 Gefitinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234921 2018-10-11

DRibble

UbiVac

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡